Our goal is to revolutionize bone regeneration for dental implants by developing superior bone graft substitute products with breakthrough technology and innovative procedure. The guiding light of the genesis of Wishbone is to design and fine-tune a high-tech recipe to extract and inactivate all proteins, including prions, from bovine bone, but which would preserve the highly osteoconductive micro and nano-topography of the natural bone. Wishbone biomaterials result from the collaboration between chemists, biomedical engineers and clinician experts in dental tissue engineering. Wishbone has invested in a high tech facility for R&D, production and QC, including a qualified ISO 7 cleanroom. The company is ISO 13485 certified.